Cumberland will be featuring ACETADOTE at these professional meetings in 2010:
| Conference | Organization | Date | Location | Website |
|---|---|---|---|---|
| Society of Critical Care Medicine | SCCM | Jan 9 - 13, 2010 | Miami | www.sccm.org |
| American Academy of Critical Care Nurses NTI - National Teaching Institute & Critical Care Exposition | AACN | May 18 - 20, 2010 | Washington DC | www.aacn.org/ntiexhibits |
| American Society of Health-System Pharmacists | ASHP | Jun 6 - 9 , 2010 | Tampa | www.ashp.org |
| Emergency Nurses Association Annual Conference | ENA | Sep 22 - 25, 2010 | San Antonio | www.ena.org |
| American College of Emergency Physicians | ACEP | Sep 28 - Oct 1, 2010 | Las Vegas | www.acep.org |
| North American Congress of Clinical Toxicology | NACCT | Oct 7 - 12, 2010 | Denver | www.clintox.org |
| American Society of Health-System Pharmacists | ASHP | Dec 5 - 9, 2010 | Anaheim | www.ashp.org |
| Society of Critical Care Medicine | SCCM | Jan 15 - 19, 2011 | San Diego | www.sccm.org |
Important Safety Information
ACETADOTE is contraindicated in patients with hypersensitivity or previous anaphylactoid reactions to acetylcysteine or any components of the preparation. Serious anaphylactoid reactions, including death in a patient with asthma, have been reported in patients administered acetylcysteine intravenously.
ACETADOTE should be used with caution in patients with asthma, or where there is a history of bronchospasm. The total volume administered should be adjusted for patients less than 40 kg and for those requiring fluid restriction. To avoid fluid overload, the volume of diluent should be reduced as needed. If volume is not adjusted, fluid overload can occur, potentially resulting in hyponatremia, seizure, and death.
Indications and Usage
Acetadote, administered intravenously within 8 to 10 hours after ingestion of a potentially hepatotoxic quantity of acetaminophen, is indicated to prevent or lessen hepatic injury.